These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pharma-Clinics. The drug of the month. Meloxicam (Mobic)]. Scheen AJ Rev Med Liege; 1997 Apr; 52(4):309-11. PubMed ID: 9273628 [No Abstract] [Full Text] [Related]
3. [Meloxicam--the balance of efficacy and safety]. Morović-Vergles J Reumatizam; 2008; 55(2):85-6. PubMed ID: 19024285 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy and tolerance of stepwise therapy with movalis in rheumatic diseases]. Tsetkova ES Ter Arkh; 2004; 76(12):78-80. PubMed ID: 15724934 [No Abstract] [Full Text] [Related]
6. Meloxicam: new formulations and their use in rheumatology. Dequeker J; Degner F Inflamm Res; 2001 Mar; 50 Suppl 1():S3-4. PubMed ID: 11339518 [No Abstract] [Full Text] [Related]
7. [New aspects of anti-inflammatory therapy of rheumatic diseases: preclinical validation and clinical trial of meloxicam]. Nasonov EL; Tsvetkova ES; Balabanova RM; Denisov LN; Alekseeva LI; Nasonova VA Klin Med (Mosk); 1996; 74(4):4-8. PubMed ID: 8999152 [No Abstract] [Full Text] [Related]
8. Meloxicam (Mobic) for osteoarthritis. Med Lett Drugs Ther; 2000 May; 42(1079):47-8. PubMed ID: 10859731 [No Abstract] [Full Text] [Related]
9. [Meloxicam: intramuscular administration in rheumatology]. Tsvetkova ES Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864 [No Abstract] [Full Text] [Related]
10. Safety of meloxicam: a global analysis of clinical trials [British Journal of Rheumatology, 1996;35(suppl. 1):68-77]. Fenn GC; Morant SV Br J Rheumatol; 1997 Jul; 36(7):817-9. PubMed ID: 9255122 [No Abstract] [Full Text] [Related]
11. Relative safety of meloxicam in NSAID-intolerant patients. Kosnik M; Music E; Matjaz F; Suskovic S Allergy; 1998 Dec; 53(12):1231-3. PubMed ID: 9930610 [No Abstract] [Full Text] [Related]
12. [The selective cox-2 inhibitor meloxicam and salicylate therapy]. Tóth K Ideggyogy Sz; 2005 May; 58(5-6):173-4. PubMed ID: 16021964 [TBL] [Abstract][Full Text] [Related]
13. Relative value of the NSAIDs, including COX-2 inhibitors and meloxicam. Curtiss FR J Manag Care Pharm; 2006 Apr; 12(3):265-8. PubMed ID: 16623613 [No Abstract] [Full Text] [Related]
14. [Meloxicam]. Sternon J; Appelboom T Rev Med Brux; 1998 Feb; 19(1):29-32. PubMed ID: 9553452 [TBL] [Abstract][Full Text] [Related]
15. [Use of movalis in treatment of dorsopathy]. Odinak MM; Emelin AIu Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):29-32. PubMed ID: 15847323 [TBL] [Abstract][Full Text] [Related]
16. [Can we treat with modern antirheumatics? Costs of NSAID treatment]. Bolten WW Pharm Unserer Zeit; 2002; 31(2):206-15. PubMed ID: 11977457 [No Abstract] [Full Text] [Related]
18. [New information on clinical efficacy and tolerance of meloxicam (movalis)]. Nasonova VA Ter Arkh; 1999; 71(11):45-8. PubMed ID: 10626335 [No Abstract] [Full Text] [Related]
19. [Acid coxibs, NO donors, cytokine inhibitors. New beginnings against rheumatism]. MMW Fortschr Med; 2002 Nov; 144(48):62. PubMed ID: 12532552 [No Abstract] [Full Text] [Related]
20. [Efficacy and intolerance of meloxicam in injection and tablet form]. Tiurin VP; Rakov AL Voen Med Zh; 2003 Nov; 324(11):54-8. PubMed ID: 14725079 [No Abstract] [Full Text] [Related] [Next] [New Search]